Literature DB >> 12970406

mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication.

Wentao Deng1, Ge Jin, Biing-Yuan Lin, Brian A Van Tine, Thomas R Broker, Louise T Chow.   

Abstract

The papillomavirus replicative helicase E1 and the origin recognition protein E2 are required for efficient viral DNA replication. We fused the green fluorescent protein (GFP) to the human papillomavirus type 11 E1 protein either in a plasmid with the E1 coding region alone (nucleotides [nt] 832 to 2781) (pGFP-11E1) or in a plasmid containing both the E1 and E2 regions (nt 2723 to 3826) and the viral origin of replication (ori) (p11Rc). The former supported transient replication of an ori plasmid, whereas the latter was a self-contained replicon. Unexpectedly, these plasmids produced predominantly a cytoplasmic variant GFP or a GFP-E1 E4 protein, respectively. The majority of the mRNAs had an intragenic or intergenic splice from nt 847 to nt 2622 or from nt 847 to nt 3325, corresponding to the E2 or E1 E4 messages. pGFP-11E1dm and p11Rc-E1dm, mutated at the splice donor site, abolished these splices and increased GFP-E1 protein expression. Three novel, alternatively spliced, putative E2 mRNAs were generated in higher abundance from the mutated replicon than from the wild type. Relative to pGFP-11E1, low levels of pGFP-11E1dm supported more efficient replication, but high levels had a negative effect. In contrast, elevated E2 levels always increased replication. Despite abundant GFP-E1 protein, p11Rc-E1dm replicated less efficiently than the wild type. Collectively, these observations show that the E1/E2 ratio is as important as the E1 and E2 concentrations in determining the replication efficiency. These findings suggest that alternative mRNA splicing could provide a mechanism to regulate E1 and E2 protein expression and DNA replication during different stages of the virus life cycle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970406      PMCID: PMC228435          DOI: 10.1128/jvi.77.19.10213-10226.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  Differential effects of the splice acceptor at nucleotide 3295 of human papillomavirus type 31 on stable and transient viral replication.

Authors:  D J Klumpp; F Stubenrauch; L A Laimins
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4.

Authors:  J Doorbar; C Foo; N Coleman; L Medcalf; O Hartley; T Prospero; S Napthine; J Sterling; G Winter; H Griffin
Journal:  Virology       Date:  1997-11-10       Impact factor: 3.616

3.  Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes.

Authors:  C Demeret; C Desaintes; M Yaniv; F Thierry
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

Review 4.  Papillomavirus DNA replication.

Authors:  L T Chow; T R Broker
Journal:  Intervirology       Date:  1994       Impact factor: 1.763

5.  Differentiation-dependent expression of E1--E4 proteins in cell lines maintaining episomes of human papillomavirus type 31b.

Authors:  T R Pray; L A Laimins
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

6.  Bovine papillomavirus type 1 DNA replication: the transcriptional activator E2 acts in vitro as a specificity factor.

Authors:  C Bonne-Andréa; F Tillier; G D McShan; V G Wilson; P Clertant
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  The functions of human papillomavirus type 11 E1, E2, and E2C proteins in cell-free DNA replication.

Authors:  J S Liu; S R Kuo; T R Broker; L T Chow
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

8.  Bovine papillomavirus E1 protein binds specifically DNA polymerase alpha but not replication protein A.

Authors:  C Bonne-Andrea; S Santucci; P Clertant; F Tillier
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

9.  Suppression of cellular proliferation by the papillomavirus E2 protein.

Authors:  J J Dowhanick; A A McBride; P M Howley
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  Co-operative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro.

Authors:  J Sedman; A Stenlund
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  14 in total

Review 1.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

2.  Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes.

Authors:  Alexandra Côté-Martin; Cary Moody; Amélie Fradet-Turcotte; Claudia M D'Abramo; Michaël Lehoux; Simon Joubert; Guy G Poirier; Benoit Coulombe; Laimonis A Laimins; Jacques Archambault
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

3.  The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci.

Authors:  Nozomi Sakakibara; Ruchira Mitra; Alison A McBride
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

4.  Phosphorylation of bovine papillomavirus E1 by the protein kinase CK2 near the nuclear localization signal does not influence subcellular distribution of the protein in dividing cells.

Authors:  Michael R Lentz; Tess Shideler
Journal:  Arch Virol       Date:  2015-10-14       Impact factor: 2.574

5.  A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.

Authors:  Margaret Rush; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation.

Authors:  Cecilia Johansson; Monika Somberg; Xiaoze Li; Ellenor Backström Winquist; Joanna Fay; Fergus Ryan; David Pim; Lawrence Banks; Stefan Schwartz
Journal:  EMBO J       Date:  2012-05-22       Impact factor: 11.598

7.  Characterization of papillomavirus E1 helicase mutants defective for interaction with the SUMO-conjugating enzyme Ubc9.

Authors:  Amélie Fradet-Turcotte; Karine Brault; Steve Titolo; Peter M Howley; Jacques Archambault
Journal:  Virology       Date:  2009-12-20       Impact factor: 3.616

Review 8.  Regulation of human papillomavirus gene expression by splicing and polyadenylation.

Authors:  Cecilia Johansson; Stefan Schwartz
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

9.  Requirement for the E1 Helicase C-Terminal Domain in Papillomavirus DNA Replication In Vivo.

Authors:  Monika Bergvall; David Gagnon; Steve Titolo; Michaël Lehoux; Claudia M D'Abramo; Thomas Melendy; Jacques Archambault
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

10.  Genomic instability of the host cell induced by the human papillomavirus replication machinery.

Authors:  Meelis Kadaja; Alina Sumerina; Tatjana Verst; Mari Ojarand; Ene Ustav; Mart Ustav
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.